1-5 of 5
Colleen K. Harvey
Close
Sort by
Journal Articles

Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial

Clinical Trials & Observations
Andrzej J. Jakubowiak, Kent A. Griffith, Donna E. Reece, Craig C. Hofmeister, Sagar Lonial, Todd M. Zimmerman, Erica L. Campagnaro, Robert L. Schlossman, Jacob P. Laubach, Noopur S. Raje, Tara Anderson, Melissa A. Mietzel, Colleen K. Harvey, Sandra M. Wear, Jennifer C. Barrickman, Craig L. Tendler, Dixie-Lee Esseltine, Susan L. Kelley, Mark S. Kaminski, Kenneth C. Anderson, Paul G. Richardson
Journal: Blood
Blood (2011) 118 (3): 535–543.
https://doi.org/10.1182/blood-2011-02-334755
Published: 2011
Journal Articles

Carfilzomib, Lenalidomide, and Dexamethasone In Newly Diagnosed Multiple Myeloma: Initial Results of Phase I/II MMRC Trial

Andrzej J Jakubowiak, MD, PhD, Dominik Dytfeld, MD, PhD, Sundar Jagannath, MD, David H. Vesole, MD, PhD, Tara B. Anderson, Brian K. Nordgren, Daniel Lebovic, MD, Keith E. Stockerl-Goldstein, MD, Kent A. Griffith, Melissa A. Hill, Colleen K. Harvey, Akari M. Dollard, Robert Ott, Susan L. Kelley, MD, Jennifer Barrickman, Michael Kauffman, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2010) 116 (21): 862.
https://doi.org/10.1182/blood.V116.21.862.862
Published: 2010
Journal Articles

The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics.

Sandra Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MBBS, MD, Mark Fiala, BS, CCRP, Sagar Lonial, MD, Dixil Francis, MPH, CCRC, David Samuel diCapua Siegel, MD, PhD, Alex Schramm, BA, Andrzej J. Jakubowiak, MD, PhD, Colleen K. Harvey, Donna E. Reece, MD, Engin Gul, HonBSc, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Buffy Jansak, BSN, OCN, Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Beth Davis, Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Angela Cisneros, Shaji Kumar, MD, Ann Birgin, CRA, Robert Ott, MBA, Leah Tasca, Susan L. Kelley, MD, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2010) 116 (21): 3803.
https://doi.org/10.1182/blood.V116.21.3803.3803
Published: 2010
Journal Articles

Lenalidomide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone In Newly Diagnosed Multiple Myeloma (MM): Final Results of Phase I/II MMRC Trial

Andrzej J Jakubowiak, MD, PhD, Donna E. Reece, MD, Craig C. Hofmeister, MD, Sagar Lonial, MD, Todd M Zimmerman, MD, Erica L. Campagnaro, MD, Robert L. Schlossman, MD, Jacob P. Laubach, MD, Noopur Raje, MD, Tara B. Anderson, Kent A. Griffith, Melissa A. Hill, Colleen K. Harvey, Sandra Wear, Jennifer Barrickman, Craig L. Tendler, MD, Dixie-Lee Esseltine, MD, Susan L. Kelley, MD, Mark S. Kaminski, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2010) 116 (21): 1937.
https://doi.org/10.1182/blood.V116.21.1937.1937
Published: 2010
Journal Articles

Final Phase I Results of Perifosine In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed or Refractory Multiple Myeloma (MM)

Andrzej J Jakubowiak, MD, PhD, Paul G Richardson, MD, Todd M Zimmerman, MD, Melissa Alsina, MD, Jonathan L. Kaufman, MD, Malathi Kandarpa, PhD, Colleen K. Harvey, Kathleen Colson, RN, BSN, BS, Monica Mitchell, RN, OCN, Teru Hideshima, MD, PhD, Peter Sportelli, Lesa Gardner, RN, Kathy Giusti, MBA, Kenneth C. Anderson, MD
Journal: Blood
Blood (2010) 116 (21): 3064.
https://doi.org/10.1182/blood.V116.21.3064.3064
Published: 2010